Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Oncology Research|March 9, 2026
Clinical Integration of Menin Inhibitors in AML: Evolving Data and Therapeutic PerspectivesTiffany Chen, Grace Kim, Yekta Rahimi, et al.Journal of Medical Cases|September 27, 2024
Combination Therapy With Asciminib and Ponatinib as a Bridge to Brexucabtagene Autoleucel and Maintenance in a Patient With Relapsed Refractory Philadelphia Positive B-Cell Acute Lymphoblastic LeukemiaAlina Amin Muhammad, Erum Mir Ghazi, Amir Ali, et al.Clinical Lymphoma, Myeloma & Leukemia|February 4, 2016
Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic SyndromeBenny Johnson, Smith Giri, Sara E Nunnery, et al.Journal of Ovarian Research|August 28, 2016
Genomic alterations in neuroendocrine cancers of the ovaryGeorge Yaghmour, Philippe Prouet, Eric Wiedower, et al.Journal of Medical Cases|January 5, 2026
Acute Myeloid Leukemia With a Non-Canonical FLT3 V491L Mutation: A Case Report With Ex Vivo FLT3 Inhibitors Sensitivity TestingMateusz Pospiech, Michelle P Ngo, Misk Alrawashdeh, et al.Frontiers in Oncology|March 20, 2026
Case Report: Complete remission of refractory Langerhans cell sarcoma following CLAG-M chemotherapy and allogeneic hematopoietic stem cell transplantAubree Mades, Lydia Chow, Alireza Ghezavati, et al.Breast Cancer Research and Treatment|June 23, 2016
Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lungBrennan McCullar, Manjari Pandey, George Yaghmour, et al.Breast Cancer Research and Treatment|October 12, 2018
Correction to: Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lungBrennan McCullar, Manjari Pandey, George Yaghmour, et al.Anticancer Research|July 29, 2016
Role of Genomic Instability in Immunotherapy with Checkpoint InhibitorsGeorge Yaghmour, Manjari Pandey, Catherine Ireland, et al.Frontiers in Oncology|February 27, 2024
Case report: Pulse cyclophosphamide for treatment of multi-agent-refractory hepatic graft-versus-host diseaseYijun Cai, Amir Ali, Elan Filler, et al.Pageof 5